Professor Gary Middleton

Professor of Medical Oncology, University of Birmingham

Professor Gary Middleton is a Medical Oncologist who specialises in lung cancer and colorectal cancer. He has many years of experience in patient treatment, and also in development of novel clinical trials. Appointed to a chair of Medical Oncology at Birmingham in 2013, he has built up a strong clinical and translational research programme. Gary also serves as a Clinical Director for the CRUK Birmingham Centre, Director of the Birmingham ECMC and is Lead for the Birmingham CRUK Clinical Academic Training Programme.

A key interest is in stratified approaches to patient treatment, and Gary has a strong presence in UK stratified medicine clinical trials. He is Chief Investigator for the National Lung Matrix Trial, a multi-centre, multi-arm, molecularly stratified clinical trial programme for UK patients with lung cancer. Outcome data was published in Nature in 2020. He is also interested in stratification approaches for immunotherapy and leads on the ANICCA trial, a phase II study in high class II expressing microsatellite stable colorectal cancer, a study directly translating the clinic work from his laboratory programme exploring the determinants and dynamics of class II expression in cancer. Another research focus is in understanding the tumour microenvironment and how this impacts on new therapeutic approaches, including novel immunotherapy strategies. One particular area of active study is myeloid derived suppressor cells (MDSC), which are thought to suppress tumour-specific immune responses. The discovery of novel predictors of checkpoint blockade toxicity is a key area of current research.

Back to Speakers

@BNOSOfficial

BNOS @BNOSOfficial   12:26 PM - Fri 18 Jun 2021

📢FREE event for Early Career Researchers - Super, not to be missed opportunity! A Roadmap to Research Independence. Online 7th July 21 12.30pm - 2pm 🖊️Sign up and more info here: https://t.co/UnRGc18ME7 🆓👍 https://t.co/yaZyyIFTbe

BNOS @BNOSOfficial   12:29 PM - Tue 8 Jun 2021

Deadline for Expressions of Interest in this role on @BNOSofficial Council. Help BNOS to fulfil its Neuro-Oncology mission to promote high-quality neuro-oncology research, education and multi-disciplinary patient centred care. https://t.co/nGhErnI53V

BNOS @BNOSOfficial   11:59 AM - Tue 1 Jun 2021

📢Thank you!👏 @BNOSofficial couldn't and wouldn't exist without our fantastic volunteers on Council. Thank you for all you do. 👍https://t.co/jziR1ONoPF Promoting high-quality multi-disciplinary neuro-oncology research, education, and patient centred care. https://t.co/xb0ud6DLNE

BNOS @BNOSOfficial   12:00 PM - Sat 29 May 2021

Are you a member of BNOS?👍Don't forget to use your 'code' to get a discount when registering for #BNOS2021 👏 Join @BNOSofficial here: https://t.co/bJLO4jxpWQ 🖊️Register for #BNOS2021 here: https://t.co/0sbI3UTD5X https://t.co/3uD2FhDCel

BNOS @BNOSOfficial   4:05 PM - Wed 26 May 2021

BNOS online Early Career Researcher Event 👏 An opportunity not to be missed! Register for your free online place here: https://t.co/gZfYIORBDd (programme may be subject to change or update) https://t.co/9gg4zsHiVl

BNOS @BNOSOfficial   12:25 PM - Wed 26 May 2021

Innovative Research at King’s Tackles Brain Tumours @BNOSofficial News! Dr Gerald Finnerty was interviewed in April 2021 by Bloomberg Radio. 📢Listen to the full interview here: https://t.co/6mCuIxzcq6 https://t.co/YJ1JsWbBMp

BNOS @BNOSOfficial   8:49 PM - Sun 23 May 2021

Don’t miss this super opportunity to submit an abstract! @NeuroOnc https://t.co/4Rt8fJJSFw